1. Below is a model of the aggrecan molecule. Over our lives the aggrecan molecule as characterized from the ECM of human patients with osteoarthritis changes in structure. Some changes include loss of the HA binding region, reduction in glycosaminoglycan number and size and so on. It is the same […]